Pharma

Nov 8 2017

Outsourcing pharma #vifor #pharma

#outsourcing pharma # Outsourcing-Pharma.com The only free online news source covering the full spectrum of contract services to the pharmaceutical and biotechnology industries, from contract research and development through to manufacturing and commercial services. Outsourcing-Pharma.com covers issues such as: off-shoring strategies the rise of contact services – in Asia and other emerging markets product safety ethical clinical trials animal testing adaptive trial design and eclinical Key Contacts Related Brands Who we are Careers with us Resources Business terms and conditions

Nov 8 2017

Novartis pharma head leaves as drug maker splits operations #helvoet #pharma

#novartis pharma # Novartis pharma head leaves as drug maker splits operations Underscoring its increasing emphasis on oncology, Novartis is splitting its prescription drug business into two organizations and hired Paul Hudson, who heads North American operations for AstraZeneca, to lead the pharmaceutical business. The newly created oncology unit, meanwhile, will be run by Bruno Strigini, who already runs the cancer-drug business. The move comes a year after Novartis purchased a portfolio of oncology medicines from GlaxoSmithKline as part of an asset swap. But Novartis is also contending with declining sales of its Gleevec cancer medicine, which has been a …

Nov 8 2017

Pharmaceutical Purified Water Newsletter» – N° 4 to 7 – METTLER TOLEDO #pharma #agency

#pharma newsletter # «Pharmaceutical Purified Water Newsletter» – N° 4 to 7 Perspectives in Pure Water Analytics Below to this section you can find all available «Pharmaceutical Purified Water News» in English for download in pdf-format. The newest release will always be placed on the bottom of the page. For more information on our pure water analytics solutions within the pharmaceutical USP industry, you can contact us by using the feedback button on the bottom of this page. We will be happy to assist you! «Pharmaceutical Purified Water News» N° 4 (12/04) – Headlines: Simplicity, the key to C lean-I …

Nov 8 2017

Novartis splits drugs business into two, pharma chief to leave #plus #pharma

#novartis pharma # Novartis splits drugs business into two, pharma chief to leave By John Miller and Ben Hirschler | ZURICH/LONDON ZURICH/LONDON (Reuters) – Novartis is splitting its pharmaceuticals division into two business units, one focused on cancer and the second on other drugs, while switching out its current pharma head in the second high-profile management reshuffle this year. David Epstein, the American head of Novartis Pharmaceuticals and a 27-year veteran with the group, will leave the company to “explore new challenges from the U.S.”, Novartis said. Epstein’s re-location to the United States implies he is not in the running …

Nov 8 2017

The Challenges Facing Emerging Markets Generic Pharmaceutical Companies #mayne #pharma

#generic pharmaceutical companies # Additional Information: The Challenges Facing Emerging Markets Generic Pharmaceutical Companies By Thomas Ansen-Wilson The US generic drug market has been quite lucrative for EM pharma companies over the last decade. Many EM pharma companies have significantly outperformed the market by leveraging solid technological capabilities and low manufacturing costs. However, the future looks more difficult as a number of changes in the US market have made the landscape increasingly challenging. In the past, when there were fewer players in the market, the first few firms to launch a generic drug were able to generate profits for a …

Nov 8 2017

Exchange-traded funds that hold big pharma – Market Realist #antares #pharma

#big pharma etf # Exchange-traded funds that hold big pharma The VanEck Vectors Pharmaceutical ETF (PPH ) This fund has been operational since 2011 and has net assets of $345.54 million. Big pharma companies like Johnson Johnson (JNJ ), Novartis AG (NVS ), and Pfizer together form 24.61% of this fund’s total assets. The Health Care Select Sector SPDR Fund (XLV ) This fund has been operational since 1998 and has net assets of $13 billion. This ETF is focused on big pharma companies, healthcare equipment and supplies, and biotechnology companies. Big pharma companies including Johnson Johnson and Pfizer (PFE …

Nov 8 2017

Pharma Pulse” Newsletter (Thai) – Issue 7 #shionogi #pharma

#pharma newsletter # “Pharma Pulse” Newsletter (Thai) Issue 7 | Oct-Nov 2014 In this latest issue, you will find beneficial contents as in the following topics New Product. 5 new consumer health products newly launched Promotion Trends. Consumer health promotion in the top retailer “Boots” in the first half-year 2014 review, a good promotion guideline for pharmacy to see what’re hot products and promotions Store Management Tips. How to manage your staff, a good framework for pharmacies’ owners to manage their business Traditional Herbs Corner :“Ginger” ordinary herbs, not only an ingredient but also a great herbs that easy to …

Nov 8 2017

The top 10 most expensive drugs of 2013 #natco #pharma

#pharmaceutical companies news # The top 10 most expensive drugs of 2013 The price of Gilead Sciences’ breakthrough drug Sovaldi has drawn all of the attention this year. By pricing it at $85,000 for a 12-week course, Gilead Sciences ($GILD) has been pilloried by politicians, payers and providers. But as EvaluatePharma points out, at that price Sovaldi barely makes it into the top 20 most expensive drugs. number 19 to be exact, just above Novartis’ ($NVS) Gleevec and just below GlaxoSmithKline’s ($GSK) Mekinist. Sovaldi is pricey, but if you want to talk about really pricey, then look at the 10 …

Nov 8 2017

Pharma Training and Education – NSF International #mds #pharma #services

#pharma training # Training and Education Pharma Biotech Training NSF International is known all over the world for the high quality of its training and education. Whether you are looking to develop one of your people for career progression (including becoming a Qualified Person), to train a group of staff in house in changes in procedures and regulations, or to bring about culture change within an entire organization, we have the skills and programs to meet your needs. We offer courses in all areas of pharmaceutical GMP, including clinical trials, as well as training ranging from Qualified Person to pharmaceutical …

Nov 8 2017

Pharma training #biochem #pharma

#pharma training # Info-tréning Bt. Gyógyszeripari szakképzések Written by Administrator | 22 May 2016 There are no translations available. Örömmel adjuk hírül, hogy 2017. januárjában új CRA csoportok indulnak (VII. évfolyam), változatlan karrierlehetőségekkel és fakultatív kórházi gyakorlattal. A képzés ára nettó 384.000Ft. 2016 október 31-ig történő befizetés esetén pedig nettó 372.000Ft. A tematika a korábbival megegyező (bal oldali menüben is leírt 6 oktatási modul) lesz, kiegészítve az ICH GCP részletes ismertetésével. A részvételi szándékot az adatok megadásával itt lehet elkötelezettség nélkül jelezni. Várunk mindenkit szeretettel! Written by Administrator | 15 April 2012 There are no translations available. Feladatunknak tekintjük, hogy …

Nov 8 2017

Takeda Oncology #sk #pharma

#pharmaceutical companies in boston # You Are Leaving Takeda Oncology You are now leaving takedaoncology.com. Links to sites outside of takedaoncology.com are provided as a resource to the viewer. takedaoncology.com accepts no responsibility for the linked sites that takedaoncology.com has no control over. To stay on the current Web site, click “Cancel.” Interacting with Takeda Oncology on Social Media Takeda Oncology recognizes the importance of social media channels in the communication space. However, in embracing these channels, we aim to engage responsibly. Below, we have outlined our current active channels as well as our terms and guidelines for interacting with …

Nov 8 2017

China – s Drug-Price Cuts Are Hitting Big Pharma Where It Hurts #pharma #test

#chinese pharmaceutical companies # China’s Drug-Price Cuts Are Hitting Big Pharma Where It Hurts The world’s largest pharmaceutical companies are facing a roadblock in China as a state-led campaign to slash drug prices has triggered a slowdown in sales growth. One of the biggest problems: China’s government-run health insurance funds, which are struggling to keep up with an ageing population and surging incidence of diseases like cancer or diabetes. As they grapple with tighter budgets and a slowing economy, many of these funds are capping reimbursements to patients and pushing local authorities to negotiate with companies to lower drug prices. …

Nov 8 2017

Confused Over New Pharma Guidelines? GCG Event Partners #pharmaceutical #reps

#pharma guidelines # Confused Over New Pharma Guidelines? Yes, it’s tax time again. And if you lose sleep just thinking about a potential audit of your own personal income because you might possibly have stretched the truth just a teensy bit about some business deductions you made last year well, consider yourself lucky you re not a meeting planner for one of the big pharmaceutical companies. It s possible they re all sleep deprived now that the Physician Payment Sunshine Act (PPSA) has taken effect. Thanks to PPSA, a key part of the federal Affordable Care Act of 2010, meeting …

Nov 8 2017

Pharma Quality Systems and Compliance – NSF International #pharma #etf

#pharma compliance # Pharma Biotech Pharma Quality Systems and Compliance Strong and robust quality systems are required for companies to consistently and reliably produce safe, high-quality products and services. Not addressing concerns highlighted in FDA 483s and FDA warning letters can potentially halt production or, worse, result in a recall, import bans, detention or product seizure, which can damage your organization s pipeline, financial well-being and reputation. With relentless, often subtle, changes to guidelines released by regulatory authorities around the world, it can be challenging to stay up to date. With substantial experience in creating, implementing, reviewing and remediating quality …

Nov 8 2017

Our Services to the Pharmaceuticals and Life Sciences Industry, PwC Canada #pharmaceutical #sales #industry

#pharmaceutical companies in canada # Pharmaceuticals and Life Sciences Helping the business of health by improving the health of business Is it any surprise that Canada’s life sciences and pharmaceutical industry receives one out of every four dollars of venture capital investment? After all, an aging Canadian population has significantly increased demand for health-related products and treatment, and the sector is working hard to keep up. With the global pharmaceutical market predicted to double to $1.8 trillion by 2020, there is a lot at stake for Canadian players in this sector. Yet there are unique challenges facing our life sciences …

Nov 8 2017

Sun Pharmaceutical Industries Share Price, NSE #jobs #in #pharmaceutical #industry

#sun pharma # Stock Price Quotes Sun Pharmaceutical Industries Ltd. Sun Pharmaceutical Industries Ltd. Sun Pharmaceutical Industries Ltd. incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 188,232.23 Cr.) operating in Pharmaceuticals and health care sector. Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Formulations which contributed Rs 5869.69 Cr to Sales Value (75.78% of Total Sales), Bulk Drugs which contributed Rs 1327.80 Cr to Sales Value (17.14% of Total Sales), Other Operating Revenue which contributed Rs 482.43 Cr to Sales Value (6.22% of Total Sales), Others which contributed Rs 64.97 Cr to …

Nov 8 2017

Guidance, Compliance, & Regulatory Information #pharmaceutical #companies #in #dallas #tx

#pharma guidelines # Guidance, Compliance, & Regulatory Information Popular Items Affordable Care Act (ACA 6004) Information on Compounding Drug Compliance Programs Guidances (Drugs) Newly Added Guidance Documents Product-Specific Recommendations for Generic Drug Development Nicotine-Containing Products Notice to Industry: Postmarketing Requirements – Postmarket studies and clinical trials Office of Compliance The Office of Prescription Drug Promotion (OPDP) PLR Requirements for Prescribing Information Regulatory Guidance Drug Registration and Listing Sunscreen Innovation Act (SIA) Unapproved Prescription Drugs: Drugs Marketed in the United States That Do Not Have Required FDA Approval Warning Letters and Notice of Violation Letters to Pharmaceutical Companies Spotlight

Nov 8 2017

EFPIA – The Pharmaceutical Industry in figures – Edition 2015 #bdi #pharma

#pharmaceutical industry statistics # The Pharmaceutical Industry in figures – Edition 2015 THE PHARMACEUTICAL INDUSTRY: A KEY ASSET TO SCIENTIFIC AND MEDICAL PROGRESS Thanks to advances in science and technology, the researchbased pharmaceutical industry is entering an exciting new era in medicines development. Research methods are evolving and we have many promising prospects on the horizon – from the possibilities offered by personalised medicines, to the potential offered by harnessing the power of big data. The innovative pharmaceutical industry is driven by, and drives, medical progress. It aims to turn fundamental research into innovative treatments that are widely available and …

Nov 8 2017

Pharmaceutical GMP – NSF International #india #pharma

#gmp pharma # Pharmaceutical GMP Course Overview “Well planned. Professional tutors. It has been a pleasure. Good with the group works and the social arrangements.” Mie Weibel / PEC, Denmark “It is a fun and relaxed way of knowing much more about GMP.” Elma Snijder / Solvay, The Netherlands “Up-to-date knowledge from (in) good presentations. Well built, easy to understand, good examples.” Tibor Erdös / Beckton Dickinson & Co, Hungary “The standard of lecturers/presenters was excellent, very impressed with the quality and completeness of the material covered.” Gerrard Kemmy / Covidien, Republic of Ireland “Superb, enjoyable and expertly delivered. Many …

Nov 8 2017

Johnson – Johnson #jobs #in #pharmaceuticals

#top pharma companies 2013 # Johnson Johnson 1. Johnson Johnson2013 revenue: $71.312 billion2012 revenue: $67.200 billion When he took over the CEO and chairman’s job at Johnson Johnson ($JNJ) in 2012, Alex Gorsky had inherited a mess from Bill Weldon. Problems in the company’s over-the-counter division were a drag on earnings, U.S. pharma sales were off and it faced a bunch of Risperdal litigation in which lawyers were itching to put the CEO in front of a jury. But just look at it now. Gorsky sits atop of a pharma company that sits atop of the group. For the first …